CRISPR & Cas Genes Market, Global Outlook and Forecast 2024-2031

Report ID: 1068631 | Published Date: Jan 2025 | No. of Page: 112 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 CRISPR & Cas Genes Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global CRISPR & Cas Genes Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global CRISPR & Cas Genes Overall Market Size
    2.1 Global CRISPR & Cas Genes Market Size: 2021 VS 2028
    2.2 Global CRISPR & Cas Genes Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top CRISPR & Cas Genes Players in Global Market
    3.2 Top Global CRISPR & Cas Genes Companies Ranked by Revenue
    3.3 Global CRISPR & Cas Genes Revenue by Companies
    3.4 Top 3 and Top 5 CRISPR & Cas Genes Companies in Global Market, by Revenue in 2021
    3.5 Global Companies CRISPR & Cas Genes Product Type
    3.6 Tier 1, Tier 2 and Tier 3 CRISPR & Cas Genes Players in Global Market
        3.6.1 List of Global Tier 1 CRISPR & Cas Genes Companies
        3.6.2 List of Global Tier 2 and Tier 3 CRISPR & Cas Genes Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global CRISPR & Cas Genes Market Size Markets, 2021 & 2028
        4.1.2 Vector-based Cas
        4.1.3 DNA-free Cas
        4.1.4 Cell Line Engineering
    4.2 By Type - Global CRISPR & Cas Genes Revenue & Forecasts
        4.2.1 By Type - Global CRISPR & Cas Genes Revenue, 2017-2022
        4.2.2 By Type - Global CRISPR & Cas Genes Revenue, 2023-2028
        4.2.3 By Type - Global CRISPR & Cas Genes Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global CRISPR & Cas Genes Market Size, 2021 & 2028
        5.1.2 Biotechnology and Pharmaceutical Companies
        5.1.3 Academics and Government Research Institutes
        5.1.4 Contract Research Organizations (CROs)
    5.2 By Application - Global CRISPR & Cas Genes Revenue & Forecasts
        5.2.1 By Application - Global CRISPR & Cas Genes Revenue, 2017-2022
        5.2.2 By Application - Global CRISPR & Cas Genes Revenue, 2023-2028
        5.2.3 By Application - Global CRISPR & Cas Genes Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global CRISPR & Cas Genes Market Size, 2021 & 2028
    6.2 By Region - Global CRISPR & Cas Genes Revenue & Forecasts
        6.2.1 By Region - Global CRISPR & Cas Genes Revenue, 2017-2022
        6.2.2 By Region - Global CRISPR & Cas Genes Revenue, 2023-2028
        6.2.3 By Region - Global CRISPR & Cas Genes Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America CRISPR & Cas Genes Revenue, 2017-2028
        6.3.2 US CRISPR & Cas Genes Market Size, 2017-2028
        6.3.3 Canada CRISPR & Cas Genes Market Size, 2017-2028
        6.3.4 Mexico CRISPR & Cas Genes Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe CRISPR & Cas Genes Revenue, 2017-2028
        6.4.2 Germany CRISPR & Cas Genes Market Size, 2017-2028
        6.4.3 France CRISPR & Cas Genes Market Size, 2017-2028
        6.4.4 U.K. CRISPR & Cas Genes Market Size, 2017-2028
        6.4.5 Italy CRISPR & Cas Genes Market Size, 2017-2028
        6.4.6 Russia CRISPR & Cas Genes Market Size, 2017-2028
        6.4.7 Nordic Countries CRISPR & Cas Genes Market Size, 2017-2028
        6.4.8 Benelux CRISPR & Cas Genes Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia CRISPR & Cas Genes Revenue, 2017-2028
        6.5.2 China CRISPR & Cas Genes Market Size, 2017-2028
        6.5.3 Japan CRISPR & Cas Genes Market Size, 2017-2028
        6.5.4 South Korea CRISPR & Cas Genes Market Size, 2017-2028
        6.5.5 Southeast Asia CRISPR & Cas Genes Market Size, 2017-2028
        6.5.6 India CRISPR & Cas Genes Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America CRISPR & Cas Genes Revenue, 2017-2028
        6.6.2 Brazil CRISPR & Cas Genes Market Size, 2017-2028
        6.6.3 Argentina CRISPR & Cas Genes Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa CRISPR & Cas Genes Revenue, 2017-2028
        6.7.2 Turkey CRISPR & Cas Genes Market Size, 2017-2028
        6.7.3 Israel CRISPR & Cas Genes Market Size, 2017-2028
        6.7.4 Saudi Arabia CRISPR & Cas Genes Market Size, 2017-2028
        6.7.5 UAE CRISPR & Cas Genes Market Size, 2017-2028
7 Players Profiles
    7.1 CRISPR Therapeutics
        7.1.1 CRISPR Therapeutics Corporate Summary
        7.1.2 CRISPR Therapeutics Business Overview
        7.1.3 CRISPR Therapeutics CRISPR & Cas Genes Major Product Offerings
        7.1.4 CRISPR Therapeutics CRISPR & Cas Genes Revenue in Global Market (2017-2022)
        7.1.5 CRISPR Therapeutics Key News
    7.2 AstraZeneca
        7.2.1 AstraZeneca Corporate Summary
        7.2.2 AstraZeneca Business Overview
        7.2.3 AstraZeneca CRISPR & Cas Genes Major Product Offerings
        7.2.4 AstraZeneca CRISPR & Cas Genes Revenue in Global Market (2017-2022)
        7.2.5 AstraZeneca Key News
    7.3 Addgene
        7.3.1 Addgene Corporate Summary
        7.3.2 Addgene Business Overview
        7.3.3 Addgene CRISPR & Cas Genes Major Product Offerings
        7.3.4 Addgene CRISPR & Cas Genes Revenue in Global Market (2017-2022)
        7.3.5 Addgene Key News
    7.4 Caribou Biosciences, Inc.
        7.4.1 Caribou Biosciences, Inc. Corporate Summary
        7.4.2 Caribou Biosciences, Inc. Business Overview
        7.4.3 Caribou Biosciences, Inc. CRISPR & Cas Genes Major Product Offerings
        7.4.4 Caribou Biosciences, Inc. CRISPR & Cas Genes Revenue in Global Market (2017-2022)
        7.4.5 Caribou Biosciences, Inc. Key News
    7.5 Cellectis
        7.5.1 Cellectis Corporate Summary
        7.5.2 Cellectis Business Overview
        7.5.3 Cellectis CRISPR & Cas Genes Major Product Offerings
        7.5.4 Cellectis CRISPR & Cas Genes Revenue in Global Market (2017-2022)
        7.5.5 Cellectis Key News
    7.6 Editas Medicine, Inc.
        7.6.1 Editas Medicine, Inc. Corporate Summary
        7.6.2 Editas Medicine, Inc. Business Overview
        7.6.3 Editas Medicine, Inc. CRISPR & Cas Genes Major Product Offerings
        7.6.4 Editas Medicine, Inc. CRISPR & Cas Genes Revenue in Global Market (2017-2022)
        7.6.5 Editas Medicine, Inc. Key News
    7.7 Egenesis
        7.7.1 Egenesis Corporate Summary
        7.7.2 Egenesis Business Overview
        7.7.3 Egenesis CRISPR & Cas Genes Major Product Offerings
        7.7.4 Egenesis CRISPR & Cas Genes Revenue in Global Market (2017-2022)
        7.7.5 Egenesis Key News
    7.8 F. Hoffmann-La Roche Ltd.
        7.8.1 F. Hoffmann-La Roche Ltd. Corporate Summary
        7.8.2 F. Hoffmann-La Roche Ltd. Business Overview
        7.8.3 F. Hoffmann-La Roche Ltd. CRISPR & Cas Genes Major Product Offerings
        7.8.4 F. Hoffmann-La Roche Ltd. CRISPR & Cas Genes Revenue in Global Market (2017-2022)
        7.8.5 F. Hoffmann-La Roche Ltd. Key News
    7.9 Horizon Discovery Group Plc
        7.9.1 Horizon Discovery Group Plc Corporate Summary
        7.9.2 Horizon Discovery Group Plc Business Overview
        7.9.3 Horizon Discovery Group Plc CRISPR & Cas Genes Major Product Offerings
        7.9.4 Horizon Discovery Group Plc CRISPR & Cas Genes Revenue in Global Market (2017-2022)
        7.9.5 Horizon Discovery Group Plc Key News
    7.10 Genscrip
        7.10.1 Genscrip Corporate Summary
        7.10.2 Genscrip Business Overview
        7.10.3 Genscrip CRISPR & Cas Genes Major Product Offerings
        7.10.4 Genscrip CRISPR & Cas Genes Revenue in Global Market (2017-2022)
        7.10.5 Genscrip Key News
    7.11 Danaher Corporation
        7.11.1 Danaher Corporation Corporate Summary
        7.11.2 Danaher Corporation Business Overview
        7.11.3 Danaher Corporation CRISPR & Cas Genes Major Product Offerings
        7.11.4 Danaher Corporation CRISPR & Cas Genes Revenue in Global Market (2017-2022)
        7.11.5 Danaher Corporation Key News
    7.12 Intellia Therapeutics, Inc.
        7.12.1 Intellia Therapeutics, Inc. Corporate Summary
        7.12.2 Intellia Therapeutics, Inc. Business Overview
        7.12.3 Intellia Therapeutics, Inc. CRISPR & Cas Genes Major Product Offerings
        7.12.4 Intellia Therapeutics, Inc. CRISPR & Cas Genes Revenue in Global Market (2017-2022)
        7.12.5 Intellia Therapeutics, Inc. Key News
    7.13 Lonza
        7.13.1 Lonza Corporate Summary
        7.13.2 Lonza Business Overview
        7.13.3 Lonza CRISPR & Cas Genes Major Product Offerings
        7.13.4 Lonza CRISPR & Cas Genes Revenue in Global Market (2017-2022)
        7.13.5 Lonza Key News
    7.14 Merck KGaA
        7.14.1 Merck KGaA Corporate Summary
        7.14.2 Merck KGaA Business Overview
        7.14.3 Merck KGaA CRISPR & Cas Genes Major Product Offerings
        7.14.4 Merck KGaA CRISPR & Cas Genes Revenue in Global Market (2017-2022)
        7.14.5 Merck KGaA Key News
    7.15 New England BioLabs
        7.15.1 New England BioLabs Corporate Summary
        7.15.2 New England BioLabs Business Overview
        7.15.3 New England BioLabs CRISPR & Cas Genes Major Product Offerings
        7.15.4 New England BioLabs CRISPR & Cas Genes Revenue in Global Market (2017-2022)
        7.15.5 New England BioLabs Key News
    7.16 Takara Bio, Inc.
        7.16.1 Takara Bio, Inc. Corporate Summary
        7.16.2 Takara Bio, Inc. Business Overview
        7.16.3 Takara Bio, Inc. CRISPR & Cas Genes Major Product Offerings
        7.16.4 Takara Bio, Inc. CRISPR & Cas Genes Revenue in Global Market (2017-2022)
        7.16.5 Takara Bio, Inc. Key News
    7.17 Synthego
        7.17.1 Synthego Corporate Summary
        7.17.2 Synthego Business Overview
        7.17.3 Synthego CRISPR & Cas Genes Major Product Offerings
        7.17.4 Synthego CRISPR & Cas Genes Revenue in Global Market (2017-2022)
        7.17.5 Synthego Key News
    7.18 Mammoth Biosciences
        7.18.1 Mammoth Biosciences Corporate Summary
        7.18.2 Mammoth Biosciences Business Overview
        7.18.3 Mammoth Biosciences CRISPR & Cas Genes Major Product Offerings
        7.18.4 Mammoth Biosciences CRISPR & Cas Genes Revenue in Global Market (2017-2022)
        7.18.5 Mammoth Biosciences Key News
    7.19 Inscripta, Inc.
        7.19.1 Inscripta, Inc. Corporate Summary
        7.19.2 Inscripta, Inc. Business Overview
        7.19.3 Inscripta, Inc. CRISPR & Cas Genes Major Product Offerings
        7.19.4 Inscripta, Inc. CRISPR & Cas Genes Revenue in Global Market (2017-2022)
        7.19.5 Inscripta, Inc. Key News
    7.20 Cibus
        7.20.1 Cibus Corporate Summary
        7.20.2 Cibus Business Overview
        7.20.3 Cibus CRISPR & Cas Genes Major Product Offerings
        7.20.4 Cibus CRISPR & Cas Genes Revenue in Global Market (2017-2022)
        7.20.5 Cibus Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. CRISPR & Cas Genes Market Opportunities & Trends in Global Market
    Table 2. CRISPR & Cas Genes Market Drivers in Global Market
    Table 3. CRISPR & Cas Genes Market Restraints in Global Market
    Table 4. Key Players of CRISPR & Cas Genes in Global Market
    Table 5. Top CRISPR & Cas Genes Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global CRISPR & Cas Genes Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global CRISPR & Cas Genes Revenue Share by Companies, 2017-2022
    Table 8. Global Companies CRISPR & Cas Genes Product Type
    Table 9. List of Global Tier 1 CRISPR & Cas Genes Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 CRISPR & Cas Genes Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global CRISPR & Cas Genes Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - CRISPR & Cas Genes Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - CRISPR & Cas Genes Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global CRISPR & Cas Genes Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - CRISPR & Cas Genes Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - CRISPR & Cas Genes Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global CRISPR & Cas Genes Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global CRISPR & Cas Genes Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global CRISPR & Cas Genes Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America CRISPR & Cas Genes Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America CRISPR & Cas Genes Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe CRISPR & Cas Genes Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe CRISPR & Cas Genes Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia CRISPR & Cas Genes Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia CRISPR & Cas Genes Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America CRISPR & Cas Genes Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America CRISPR & Cas Genes Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa CRISPR & Cas Genes Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa CRISPR & Cas Genes Revenue, (US$, Mn), 2023-2028
    Table 30. CRISPR Therapeutics Corporate Summary
    Table 31. CRISPR Therapeutics CRISPR & Cas Genes Product Offerings
    Table 32. CRISPR Therapeutics CRISPR & Cas Genes Revenue (US$, Mn), (2017-2022)
    Table 33. AstraZeneca Corporate Summary
    Table 34. AstraZeneca CRISPR & Cas Genes Product Offerings
    Table 35. AstraZeneca CRISPR & Cas Genes Revenue (US$, Mn), (2017-2022)
    Table 36. Addgene Corporate Summary
    Table 37. Addgene CRISPR & Cas Genes Product Offerings
    Table 38. Addgene CRISPR & Cas Genes Revenue (US$, Mn), (2017-2022)
    Table 39. Caribou Biosciences, Inc. Corporate Summary
    Table 40. Caribou Biosciences, Inc. CRISPR & Cas Genes Product Offerings
    Table 41. Caribou Biosciences, Inc. CRISPR & Cas Genes Revenue (US$, Mn), (2017-2022)
    Table 42. Cellectis Corporate Summary
    Table 43. Cellectis CRISPR & Cas Genes Product Offerings
    Table 44. Cellectis CRISPR & Cas Genes Revenue (US$, Mn), (2017-2022)
    Table 45. Editas Medicine, Inc. Corporate Summary
    Table 46. Editas Medicine, Inc. CRISPR & Cas Genes Product Offerings
    Table 47. Editas Medicine, Inc. CRISPR & Cas Genes Revenue (US$, Mn), (2017-2022)
    Table 48. Egenesis Corporate Summary
    Table 49. Egenesis CRISPR & Cas Genes Product Offerings
    Table 50. Egenesis CRISPR & Cas Genes Revenue (US$, Mn), (2017-2022)
    Table 51. F. Hoffmann-La Roche Ltd. Corporate Summary
    Table 52. F. Hoffmann-La Roche Ltd. CRISPR & Cas Genes Product Offerings
    Table 53. F. Hoffmann-La Roche Ltd. CRISPR & Cas Genes Revenue (US$, Mn), (2017-2022)
    Table 54. Horizon Discovery Group Plc Corporate Summary
    Table 55. Horizon Discovery Group Plc CRISPR & Cas Genes Product Offerings
    Table 56. Horizon Discovery Group Plc CRISPR & Cas Genes Revenue (US$, Mn), (2017-2022)
    Table 57. Genscrip Corporate Summary
    Table 58. Genscrip CRISPR & Cas Genes Product Offerings
    Table 59. Genscrip CRISPR & Cas Genes Revenue (US$, Mn), (2017-2022)
    Table 60. Danaher Corporation Corporate Summary
    Table 61. Danaher Corporation CRISPR & Cas Genes Product Offerings
    Table 62. Danaher Corporation CRISPR & Cas Genes Revenue (US$, Mn), (2017-2022)
    Table 63. Intellia Therapeutics, Inc. Corporate Summary
    Table 64. Intellia Therapeutics, Inc. CRISPR & Cas Genes Product Offerings
    Table 65. Intellia Therapeutics, Inc. CRISPR & Cas Genes Revenue (US$, Mn), (2017-2022)
    Table 66. Lonza Corporate Summary
    Table 67. Lonza CRISPR & Cas Genes Product Offerings
    Table 68. Lonza CRISPR & Cas Genes Revenue (US$, Mn), (2017-2022)
    Table 69. Merck KGaA Corporate Summary
    Table 70. Merck KGaA CRISPR & Cas Genes Product Offerings
    Table 71. Merck KGaA CRISPR & Cas Genes Revenue (US$, Mn), (2017-2022)
    Table 72. New England BioLabs Corporate Summary
    Table 73. New England BioLabs CRISPR & Cas Genes Product Offerings
    Table 74. New England BioLabs CRISPR & Cas Genes Revenue (US$, Mn), (2017-2022)
    Table 75. Takara Bio, Inc. Corporate Summary
    Table 76. Takara Bio, Inc. CRISPR & Cas Genes Product Offerings
    Table 77. Takara Bio, Inc. CRISPR & Cas Genes Revenue (US$, Mn), (2017-2022)
    Table 78. Synthego Corporate Summary
    Table 79. Synthego CRISPR & Cas Genes Product Offerings
    Table 80. Synthego CRISPR & Cas Genes Revenue (US$, Mn), (2017-2022)
    Table 81. Mammoth Biosciences Corporate Summary
    Table 82. Mammoth Biosciences CRISPR & Cas Genes Product Offerings
    Table 83. Mammoth Biosciences CRISPR & Cas Genes Revenue (US$, Mn), (2017-2022)
    Table 84. Inscripta, Inc. Corporate Summary
    Table 85. Inscripta, Inc. CRISPR & Cas Genes Product Offerings
    Table 86. Inscripta, Inc. CRISPR & Cas Genes Revenue (US$, Mn), (2017-2022)
    Table 87. Cibus Corporate Summary
    Table 88. Cibus CRISPR & Cas Genes Product Offerings
    Table 89. Cibus CRISPR & Cas Genes Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. CRISPR & Cas Genes Segment by Type in 2021
    Figure 2. CRISPR & Cas Genes Segment by Application in 2021
    Figure 3. Global CRISPR & Cas Genes Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global CRISPR & Cas Genes Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global CRISPR & Cas Genes Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by CRISPR & Cas Genes Revenue in 2021
    Figure 8. By Type - Global CRISPR & Cas Genes Revenue Market Share, 2017-2028
    Figure 9. By Application - Global CRISPR & Cas Genes Revenue Market Share, 2017-2028
    Figure 10. By Region - Global CRISPR & Cas Genes Revenue Market Share, 2017-2028
    Figure 11. By Country - North America CRISPR & Cas Genes Revenue Market Share, 2017-2028
    Figure 12. US CRISPR & Cas Genes Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada CRISPR & Cas Genes Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico CRISPR & Cas Genes Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe CRISPR & Cas Genes Revenue Market Share, 2017-2028
    Figure 16. Germany CRISPR & Cas Genes Revenue, (US$, Mn), 2017-2028
    Figure 17. France CRISPR & Cas Genes Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. CRISPR & Cas Genes Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy CRISPR & Cas Genes Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia CRISPR & Cas Genes Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries CRISPR & Cas Genes Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux CRISPR & Cas Genes Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia CRISPR & Cas Genes Revenue Market Share, 2017-2028
    Figure 24. China CRISPR & Cas Genes Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan CRISPR & Cas Genes Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea CRISPR & Cas Genes Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia CRISPR & Cas Genes Revenue, (US$, Mn), 2017-2028
    Figure 28. India CRISPR & Cas Genes Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America CRISPR & Cas Genes Revenue Market Share, 2017-2028
    Figure 30. Brazil CRISPR & Cas Genes Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina CRISPR & Cas Genes Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa CRISPR & Cas Genes Revenue Market Share, 2017-2028
    Figure 33. Turkey CRISPR & Cas Genes Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel CRISPR & Cas Genes Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia CRISPR & Cas Genes Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE CRISPR & Cas Genes Revenue, (US$, Mn), 2017-2028
    Figure 37. CRISPR Therapeutics CRISPR & Cas Genes Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. AstraZeneca CRISPR & Cas Genes Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Addgene CRISPR & Cas Genes Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Caribou Biosciences, Inc. CRISPR & Cas Genes Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Cellectis CRISPR & Cas Genes Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Editas Medicine, Inc. CRISPR & Cas Genes Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Egenesis CRISPR & Cas Genes Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. F. Hoffmann-La Roche Ltd. CRISPR & Cas Genes Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Horizon Discovery Group Plc CRISPR & Cas Genes Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Genscrip CRISPR & Cas Genes Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. Danaher Corporation CRISPR & Cas Genes Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. Intellia Therapeutics, Inc. CRISPR & Cas Genes Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 49. Lonza CRISPR & Cas Genes Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 50. Merck KGaA CRISPR & Cas Genes Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 51. New England BioLabs CRISPR & Cas Genes Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 52. Takara Bio, Inc. CRISPR & Cas Genes Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 53. Synthego CRISPR & Cas Genes Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 54. Mammoth Biosciences CRISPR & Cas Genes Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 55. Inscripta, Inc. CRISPR & Cas Genes Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 56. Cibus CRISPR & Cas Genes Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
112
Frequently Asked Questions
CRISPR & Cas Genes Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
CRISPR & Cas Genes Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
CRISPR & Cas Genes Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports